Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 31 EP applications Frank F.R. Daelemans has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12712666

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/505, A61K 31/506, C07D 239/48, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
EXAMINATION IN PROGRESS
EP12721852

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/517, A61P 31/00, C07D 239/95
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
GRANT OF PATENT INTENDED
EP12738060

DARUNAVIR COMBINATION FORMULATIONS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/34, A61K 31/5377, A61P 31/18
Applicant:
Janssen Research & Development Ireland
Applicant:
Gilead Sciences Inc
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
GRANT OF PATENT INTENDED
EP12732668

DARUNAVIR FORMULATIONS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/34, A61P 31/18
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
PATENT GRANTED
EP12784574

PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/522, A61P 31/12, C07D 473/34, C07D 519/00
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP12809772

HIV MEMBRANE FUSION INHIBITORS

IPC classification:
C07K 14/005, C07K 14/16
Applicant:
Pepscan Systems BV
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP12810312

QUINAZOLINONE DERIVATIVES AS HCV INHIBITORS

IPC classification:
A61K 31/517, A61P 31/12, C07D 403/14, C07D 491/113
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
PATENT GRANTED
EP12810310

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

IPC classification:
A61K 31/4412, A61K 31/506, A61K 31/513, A61K 31/527, A61P 31/14, C07D 401/14, C07D 403/14, C07D 491/10
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13703055

PIPERIDINO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/519, A61P 31/00, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
EXAMINATION IN PROGRESS
EP13722334

POLYINOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

IPC classification:
A61K 9/00, A61K 9/16, A61K 31/713, A61K 47/24, A61K 47/36, A61K 47/38, A61P 11/00, A61P 31/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13727945

A METHOD FOR THE PREPARATION OF 3-AMINO-N-CYCLOPROPYL-2-HYDROXYL-HEXANAMIDE

IPC classification:
C07C 231/02
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735321

MACROCYCLIC PURINES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/52, A61P 31/00, C07D 487/16, C07D 498/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
PATENT GRANTED
EP13748289

ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/505, A61K 31/506, A61P 31/00, A61P 35/00, C07D 239/48, C07D 401/06, C07D 409/06
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13762816

POTENTIOMETRIC SENSOR

IPC classification:
B01D 69/12, B01D 69/14, C07F 9/10, C12Q 1/00, G01N 27/333, G01N 33/543
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP13779156

ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/505, A61P 31/12, C07D 213/75, C07D 239/48
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP13779766

PYRROLO[3,2-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES

IPC classification:
A61K 31/519, A61P 29/00, A61P 31/12, A61P 37/00, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13789821

HETEROCYCLIC SUBSTITUTED 2-AMINO-QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/505, A61P 31/12, C07D 239/95
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14705356

2-AMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/505, A61P 31/12, C07D 239/48
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP14717689

MACROCYCLIC DEAZA-PURINONES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/522, C07D 473/00
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14718588

QUASISPECIES ANALYSIS OF JC VIRUS DNA PRESENT IN URINE OF HEALTHY SUBJECTS

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Janssen Diagnostics BVBA
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14725996

PYRIDONE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/506, C07D 401/06
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP14744834

THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/519, A61P 37/04, C07D 495/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP14738751

PYRROLO [3,2-D] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES

IPC classification:
A61K 31/519, A61P 31/12, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
The patent has been granted
EP11711573

MACROCYCLIC INTEGRASE INHIBITORS

IPC classification:
A61K 31/529, A61P 31/18, C07D 487/18, C07D 498/18, C07D 515/18
Applicant:
Janssen Research & Development Ireland
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14793168

POLYLNOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

IPC classification:
A61K 9/16, A61K 31/787, A61K 47/26, A61K 47/36, A61K 47/38, A61P 31/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15706426

IDENTIFICATION OF JC VIRAL EPITOPES BY CYTOTOXIC T LYMPHOCYTES IN HEALTHY INDIVIDUALS AND THEIR USE IN ASSAYS

IPC classification:
G01N 33/569, G01N 33/68
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15720010

USE OF A HIV DERIVED ACCESSORY PROTEIN FOR THE REACTIVATION OF LATENT HIV

IPC classification:
A61K 38/16, C07K 14/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15750365

INDOLES FOR USE IN INFLUENZA VIRUS INFECTION

IPC classification:
A61P 31/16, C07D 401/14, C07D 403/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15745483

COMPACTED SOLID DOSAGE FORM

IPC classification:
A61K 9/20, A61K 39/395
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15760159

PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION

IPC classification:
A61K 31/519, A61P 31/16, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
Request for examination was made
EP16700810

INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS

IPC classification:
A61K 31/404, A61P 31/12, C07D 209/14
Applicant:
Katholieke Universiteit Leuven
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
Request for examination was made

Please Sign in to use this feature